Monica Xiong

Washington University

$85,804

Attributed

$85,804

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $30.9K · FY2018–20

$50K$37.5K$25K$12.5K$0

'18

'19

'20

Funding mix

By agency

NIH$85,804 · 1

By mechanism

F31$85,804 · 1

Top collaborators

No co-investigators on record.

Most similar at Washington University

Same institution · by research overlap

Others in their field

Other Emerging Leaders on “Cerebral Amyloid Angiopathy”

Matthew Schrag · Vanderbilt University Medical Center$6,454,767
Silvia Fossati · New York University School Of Medicine$5,537,998
Matthew Flaherty · Johns Hopkins University$4,476,529
Hemali Phatnani · New York University School Of Medicine$4,131,454
Susanne Janneke Van Veluw · Massachusetts General Hospital$4,096,557
Hyung Jin Ahn · Rockefeller University$3,716,874

Research focus

Cerebral Amyloid AngiopathyAffectAge Related NeurodegenerationAllelesAlzheimer&AposAmericanAmyloidAmyloid Beta-ProteinAnimal ModelAntibodiesAntibody TherapyApolipoprotein EApolipoprotein E-4AstrocytesBeta Amyloid PathologyBeta SecretaseBindingBiochemicalBlood VesselsBrainCardiovascular SystemCellsCephalicCerebrovascular Circulation

Grant awards (3)

The efficacy of human apolipoprotein E4 immunotherapy on cerebral amyloid angiopathy and vascular dysfunction in 5XFAD/apoE4 mice$24,428

F31 · FY2020 · AG · contact PI

The efficacy of human apolipoprotein E4 immunotherapy on cerebral amyloid angiopathy and vascular dysfunction in 5XFAD/apoE4 mice$30,934

F31 · FY2019 · AG · contact PI

The efficacy of human apolipoprotein E4 immunotherapy on cerebral amyloid angiopathy and vascular dysfunction in 5XFAD/apoE4 mice$30,442

F31 · FY2018 · AG · contact PI